Practice of Pharmaceutical Outpatient Service for Medication Therapy Management of A Case of Patient with Latent Autoimmune Diabetes in Adults
10.3870/j.issn.1004-0781.2025.03.023
- VernacularTitle:1例成人隐匿性自身免疫糖尿病患者药物治疗管理的药学门诊服务实践
- Author:
Qun ZHAO
1
;
Ximei SUN
;
Jing LI
;
Jigang SI
;
Ting GAO
Author Information
1. 山东省淄博市中心医院药学部,淄博 255036
- Publication Type:Journal Article
- Keywords:
Pharmaceutical outpatient service;
Latent autoimmune diabetes in adults(LADA);
Medication therapy management(MTM)
- From:
Herald of Medicine
2025;44(3):473-478
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize a case of latent autoimmune diabetes in adults(LADA)who received medication therapy management(MTM)of pharmaceutical outpatient service,and to provide reference for the treatment of similar diseases.Methods The physician recommended a 61-year-old male patient with LADA to the pharmacy clinic on March 27,2023.The pharmacists provided MTM services for the patient through pharmacy inquiry,medication evaluation,medication reconciliation,medication education,and pharmacy follow-up,return visit or pharmacy follow-up for the patient once a week,and established the patient MTM archives.Results Through fifteen MTM services for over three months,including eight visits to the pharmaceuti-cal outpatient clinic and follow-up seven times.On July 10,2023,the atherosclerotic cardiovascular disease(ASCVD)monitoring indicators,such as fasting plasma glucose(FPG),glycosylated hemoglobin(HbA1c),blood pressure,heart rate,low density lipo-protein cholesterol(LDL-C),and homocysteine(HCY),reduced from 7.17 mmol·L-1,6.8％,140-150/90-100 mmHg,80-90 times·min-1,2.15 mmol·L-1,16.30 μmol·L-1 to 6.06 mmol·L-1,6.1％,120-130/70-80 mmHg,60-70 times·min-1,1.63 mmol·L-1,8.67 μmol·L-1 after MTM services.The ASCVD monitoring indicators were effectively controlled.After thirty-two weeks,the re-examination of the patient's fasting C-P level remained stable,there was no significant decline in pancreas islet function,and cardiac ultrasound showed that cardiac function had a certain improvement.Conclusion By providing MTM serv-ices and reconciliation the medication regimen for the patient with LADA,the ASCVD monitoring indicators such as blood glu-cose,blood pressure,blood lipids,heart rate,and homocysteine were controlled to meet the standards,effectively protecting the pancreatic β-cell and target organs functions of the patient,and significantly improving his health management level.
